EVENTS AND TRAINING |
IMCAS: 15 years of diversity, dedication and scientific innovation
F
ifteen years after its very first congress, IMCAS has grown into one of the finest teaching events in
plastic surgery and cosmetic dermatology, firstly by building the first true interface between these disciplines, and secondly by anticipating upcoming trends, emergent markets, and taking risks that end up rewarding. However, while growing in size,
IMCAS has always stayed true to its core values, and reinforced them by building partnerships with worldwide scientific societies. Now one of the most important
international courses dedicated to plastic surgery and cosmetic dermatology, IMCAS will welcome more than 4500 delegates at its next annual conference. Its main objective is to promote the highest possible standards in clinical practice, education and research at the plastic surgery/ dermatology interface, as well as in related disciplines (e.g. facial plastic surgery, oculoplastic surgery, aesthetic medicine, research). It is now an institutional teaching
congress, working with some of the most well-known societies, such as the SOFCEP (French Society of Aesthetic Surgery), the ESLD (European Society for Laser Dermatology) and the ASDS (American Society for Dermatologic Surgery).
Leading and innovative subjects IMCAS's first strength has always been its scientific programme. A teaching event before anything else, each year the congress
gathers the best practitioners and key opinion leaders from across the globe on its board and scientific committee. A team highly renowned plastic
surgeons and dermatologists create a state-of-the-art programme for each conference, always aiming to cover the major subjects and follow the current trends and scientific truth. IMCAS's congress programmes
72 ❚
are therefore continually evolving to fit the hosting area topics and to integrate the latest news, innovations and advances of this field of medicine. Never afraid to address sensitive issues and topics, IMCAS tends to choose controversy over consensus, with more than one session devoted to the subtle subject of complications, usually covering all the latest procedures. Eyelid and face lift surgeries, hand rejuvenation, rhinoplasty, breast and buttock augmentation, laser or injectable treatments have, among many others, benefited from full sessions discussing their complications. Going one step further, IMCAS launched — at its 2012 Annual Meeting — its first worldwide survey; a fully anonymous data collection on fillers complications. Approximately 500 practitioners from all over the globe reported complications using specific fillers. The results of that survey were analysed and featured during a 2-hour special session at IMCAS 2012, and will be published in a 2013 special issue. At every congress IMCAS offers a number of open debates, clinical cases and comparative technologies. For the 2013 Paris congress, a room will be dedicated to characteristic comparisons of a number of products and devices (e.g. cellulite, RF, breast implants and fillers), which will again be published in the same issue.
Product Portfolio |
prime-journal.com
Interactive formats to promote exchange Interactivity is another component of IMCAS programmes, which offer a range of tutorial sessions, a narrower format allowing in-depth coverage of a single subject, and promoting a more practical approach. Interactivity is also provided
through the use of cutting-edge technology. Live demonstrations have always been part of IMCAS conferences, but the concept has been extended with live workshops, CME-certified courses and the latest IMCAS special sessions, showcasing
surgery
demonstrations on cadavers and patients, live broadcasts from the OR, and allowing the audience to interact with the practitioners on site. For the 2013 Annual Meeting, those live workshops will be dedicated to injectable fillers and toxins, and lipofilling and stem cells for breast and buttock.
Addressing all needs In addition to its excellent scientific
contents, IMCAS is also interested in addressing issues and questions beyond the practice as a medical gesture. The 2013 congress will particularly highlight the following: ■ Operative security ■ Evidence-based medicine
■ The relationship between doctors and the pharmaceutical industry
■ The aftermath of the PIP crisis ■ The therapeutic function of aesthetic medicine. In short, the social, economic
and practical aspects of being an aesthetic practitioner are also addressed at IMCAS, with a welcoming experience and advice from all attendees.
IMCAS as a talent scout Encouraging active participation from its attendees is one of the trademarks of IMCAS; we encourage attendees to step forward with their own ideas and material. The congress therefore offers no less than five types of abstract submission — from contributing lectures integrated within the programme, to clinical studies awarded during a beautiful ceremony. Free Communication Sessions
allow physicians to submit their presentations for oral lecture, poster or e-paper, while New Devices and Products welcome the submissions of inventors and engineers who want doctors to be aware of the latest advances of their R&D department.
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76